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5 cross-hybridizing cDNA clones of sizes 2.2 (3 cDNAs), 1.3 and 0.8 kb corresponding to tau microtubule- 
associated protein have been isolated from a rat brain lgtl 1 expression library. Antibodies affinity-purified 
using the fusion protein encoded by the cDNAs were observed to label tau polypeptides on Western blots 
and Alzheimer’s neurofibrillary tangles. 
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1. INTRODUCTION 
Several proteins promote the in vitro 
polymerization of tubulin and co-assemble with 
tubulin to form microtubules. These include tau 
proteins (55-68 kDa) [l], MAPS, 1 and 2 
(270-350 kDa) [2], and some more recently 
described MAPS ranging from 120 to 240 kDa [3]. 
In adult rat brain, tau proteins are composed of at 
least 4 major polypeptides, as judged by one- 
dimensional SDS-polyacrylamide gel elec- 
trophoresis [ 1,4-61. The polypeptide complement 
of tau changes as development proceeds, for exam- 
ple in newborn rat brain, tau has been reported to 
be composed of only two polypeptides which are 
progressively replaced by the adult pattern [7]. 
The different tau polypeptides have been found 
to be homologous by peptide mapping [8] and by 
immunochemical analysis, including cross- 
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reactivity with monoclonal antibodies [4,5]. The 
microheterogeneity is, in part, due to different 
phosphorylation states [9,10] but also arises from 
different primary translation products [ 11,121. 
Neurofibrillary tangles (NFT) in Alzheimer’s 
disease are one of the neuropathological hallmarks 
of the disease. They comprise bundles of abnormal 
filaments (paired helical filaments, PHF) ac- 
cumulating in neurones. PHF possess unique 
ultrastructural features [ 131, distinguishing them 
from microtubules and neurofilaments, the normal 
fibrous organelles that constitute the neuronal 
cytoskeleton. Despite these morphological dif- 
ferences, PHF share epitopes with several 
cytoskeletal proteins: PHF react with antibodies 
directed against phosphorylated epitopes present 
on the C-terminal domains of the largest neurofila- 
ment polypeptides (NF-H and NF-M) [ 141 and 
with antibodies against the microtubule-associated 
proteins tau [15-191 and MAP2 [20,21]. It is not 
known whether all or only some species of tau are 
involved in the PHF. 
We report here the isolation of putative tau 
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cDNAs from a rat brain expression library, and 
provide evidence that these cDNAs code for 
epitopes present on PHF. 
2. MATERIALS AND METHODS 
2.1. RNA isolation and preparation of cDNA 
library 
Rat and post-mortem human brain RNA was 
prepared by the guanidinium thiocyanate extrac- 
tion procedure [22]. 10 pg rat polyadenylated RNA 
isolated by oligo(dT)-cellulose chromatography 
were used to prepare cDNA [23] which was in- 
serted into the EcoRI site of the bacteriophage x- 
pression vector Agtl 1 [24]. 
2.2. Preparation of antiserum and library 
screening 
The rabbit polyclonal anti-tau serum [15] was 
stripped of anti-E. coli antibodies and the library 
screening performed as reported in [25], 
substituting protein A-alkaline phosphatase for 
protein A-peroxidase. 
2.3. Immunochemistry 
The fusion proteins encoded by each putative 
tau clone were transferred as hgtl 1 plaques from 
A B C D E 
5kb- 
2kb- 
agar plates to nitrocellulose filters and antibodies 
were affinity-purified from the serum by elution 
from these nitrocellulose filters [26]. These an- 
tibodies were tested on Western blots of ther- 
mostable microtubule-associated proteins WI 
prepared from microtubules polymerized in vitro 
]271. 
The affinity-purified antibodies were also tested 
for their reactivity with neurofibrillary tangles by 
immunocytochemistry on tissue sections in light 
and electron microscopy [ 14,151. 
3. RESULTS 
A library of lo6 recombinant phages was 
generated and 1.7 x lo5 plaques screened with the 
anti-tau serum. Five positive clones were detected, 
with cDNA insert sizes of 0.8, 1.3, and three in- 
serts of 2.2 kb, as determined by agarose gel elec- 
trophoresis. By Southern blot analysis the five 
-67 
430 
A B 
Fig.2. Characterization of the antibody selected by 
ptau/l cDNA-encoded fusion protein. (A) Coomassie 
blue staining of rat brain thermostable microtubule- 
associated proteins. Arrows indicate MAP2 and tau 
proteins. (B) Immunoblotting of the same preparation 
with the antibody affinity-purified from the serum using 
the fusion protein expressed by ptau/l clone. 
Fig. 1. Northern blot analysis using ptau/6 cDNA. Lanes 
A-E, RNA from: A, kidney; B, muscle; C, liver; D, 
brain from 3 day-old rat; E, brain from adult rat. 
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cDNAs were observed to cross-hybridize (not 
shown). One of the 2.2 kb inserts, designated 
ptau/6, was subcloned in plasmid pAT153. Nor- 
thern blot analysis of adult rat brain RNA in- 
dicated that ptau/6 cDNA gives a signal at 6 kb 
but no hybridization was observed on rat liver, 
kidney or muscle RNA (fig.l). A signal at 6.2 kb 
was also observed using 3-day-old rat brain RNA 
(fig. lD), and a weaker hybridization was seen with 
human RNA (not shown). 
sections of human brain in light and electron 
microscopy (fig.3), indicating that the epitopes 
present on the putative tau fusion proteins are 
shared with tangles. 
4. DISCUSSION 
Affinity-purified antibodies labeled, in each 
case, several proteins with positions corresponding 
to 3 tau polypeptides on Western blots of ther- 
mostable microtubule-associated proteins that are 
enriched for tau and MAP2 (fig.2). In addition, 
these affinity-purified antibodies showed a weak 
cross-reactivity with MAP2. The fusion proteins 
were also labeled on Western blots by the anti-tau 
serum (not shown). 
The following criteria were thus used to establish 
that our five clones code for putative tau mRNAs: 
(i) the cDNAs hybridize to a brain-specific 
messenger, whose size is similar to that previously 
reported for tau mRNA [12,28]; (ii) antibodies, 
affinity-purified using the fusion proteins, are 
specific for proteins with properties consistent with 
them being identified as tau polypeptides (ther- 
mostable microtubule-associated proteins with 
molecular mass between 50 and 70 kDa); (iii) the 
fusion proteins are labeled by the anti-tau serum 
on Western blots. 
The same affinity-purified antibodies labeled Drubin et al. [12] have reported the isolation of 
only Alzheimer neurofibrillary tangles on tissue mouse tau cDNAs which hybridize to a 6 kb band 
Fig.3. Immunolabeling of Alzheimer’s neurofibrillary tangles by ptau/6 affinity-purified antibody. (A) Paraffin section 
of hippocampus; scale bar, 5 pm. (B) Ultrathin section of a cortical tissue sample; scale bar, 100 nm. 
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by Northern analysis. A tau mRNA of the same 
size in rat, mouse and fetal human brain was con- 
firmed by Neve et al. [28], who also reported a 
developmental shift in the size of tau mRNA, i.e. 
a 6.5 kb band in adult rodent brain and a 6.0 kb 
in fetal and post-natal rodent brain. At variance 
with these reports, Ginzburg et al. [l l] have 
observed that rat tau mRNA has a size of 2.2 kb, 
as judged from in vitro translation of size- 
fractionated RNA but the reason for the 
discrepancy between this report and those of 
Drubin et al. [12], Neve et al. [28] and our data has 
yet to be resolved. 
Our observation that our 5 putative tau clones 
cross-hybridize shows that they contain sequences 
derived from the same messenger, or from related 
messengers of the same size, since only one band 
was detected on Northern blots. The existence of 
several messengers for different tau isoforms has 
been suggested [ 11,121 because tau heterogeneity is 
observed in in vitro translation products and ac- 
cording to the developmental stages from which 
mRNA is translated in vitro these products vary in 
pattern on SDS-PAGE. Definitive proof of multi- 
ple protein sequences must await sequence analysis 
of tau cDNAs. 
The affinity-purified antibodies, even those ob- 
tained using the smallest 0.8 kbp clone, label 
several tau species, confirming that the latter share 
epitopes [4,5]. We observed that there is a 
developmental shift in the size of tau mRNA, 
although this shift is the reverse of that reported by 
Neve et al. [28]. This is consistent with the 
hypothesis of several tau mRNAs of the same 
range of size that show a developmental 
heterogeneity. Our cDNA clones could therefore 
be selective for different tau mRNA species from 
those detected by the previously published clones 
LW. 
Affinity-purified antibodies were observed to 
cross-react with MAP2. A cross-reaction between 
MAP2 and tau has been reported [21]. However, 
our ptau/6 cDNA, at the stringency used, only 
recognized a 6 kb mRNA, whereas a 9 kb mRNA 
has been observed for MAP2 [29]. Tau and MAP2 
can compete for the same tubulin-binding site [30] 
and ptau/6 could encode an immunochemically 
cross-reactive sequence common to the two pro- 
teins and involved in this binding site. 
Axonal labeling, which has been observed by im- 
munocytochemistry on fresh rat brain with anti- 
tau antibodies [4], was not observed on post- 
mortem human brain tissue sections and this too is 
a characteristic of anti-tau antibodies: tau epitopes 
associated with tangles are resistant to post- 
mortem autolysis and/or tissue processing, 
whereas, normal microtubule-associated tau is 
labile. It has also been reported that tau epitopes 
on neurofibrillary tangles are abnormally 
phosphorylated [31]. However, we show here that 
anti-tau antibodies against most probably un- 
phosphorylated fusion proteins (phosphorylation 
being a post-translational event) label tangles. 
These results indicate that our putative tau cDNAs 
encode protein sequences that are present in 
tangles although the presence of fortuitously 
shared epitopes on unrelated proteins in tangles, 
rather than tau per se, cannot at this stage be ex- 
cluded. Further work is now required to establish 
the extent of cross-reactivity between tangles and 
the putative tau proteins encoded by the cDNA 
clones and this should also serve the purpose of in- 
creasing our knowledge of the polypeptide com- 
position of tangles. 
These cDNAs may also enable us to study the 
genetic control of tau protein expression in normal 
brain and in several neurological diseases where 
tau protein has been found to be associated with 
abnormalities of the neuronal cytoskeleton. 
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